Company Filing History:
Years Active: 2019-2023
Title: Anmarie Boutrin: Innovator in Cancer Treatment
Introduction
Anmarie Boutrin is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic antibodies. With a total of 3 patents, her work focuses on advancing medical solutions for patients suffering from tumors.
Latest Patents
Among her latest patents, Anmarie has developed methods for treating B7-H1-expressing tumors. One of her notable patents involves the use of Anti-B7-H1 antibodies, specifically MEDI4736 or an antigen-binding fragment thereof, to effectively target and treat these tumors. This innovative approach holds promise for improving treatment outcomes in oncology.
Career Highlights
Anmarie Boutrin is currently associated with MedImmune Limited, where she continues to push the boundaries of cancer research. Her dedication to developing effective therapies has positioned her as a key figure in the medical community.
Collaborations
Throughout her career, Anmarie has collaborated with esteemed colleagues, including Rajesh Narwal and David Fairman. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.
Conclusion
Anmarie Boutrin's contributions to the field of cancer treatment through her innovative patents and collaborations highlight her commitment to improving patient care. Her work continues to inspire advancements in medical research and therapeutic development.